← back to search

Juping Zhang

Guangzhou University of Chinese Medicine · CN
Area of research
Molecular Biology · Organic Chemistry
Research interest
Research focused on Breast cancer and Cancer research, with related work in CXCL1, Metastasis, Ralstonia solanacearum. Notable publications include 'Synthesis and biological activity of myricetin derivatives containing 1,3,4-thiadiazole scaffold', 'Ursolic Acid Inhibits Breast Cancer Metastasis by Suppressing Glycolytic Metabolism via Activating SP1/Caveolin-1 Signaling', and 'Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway'.
h-index
citations
398
works
19
NIH funding
primary concept
email

Recent publications

Clinical efficacy and multi-omics analysis of Si–Ni–San for depression treatment in breast cancer patients: a randomized, double-blind, placebo-controlled, crossover trial
Chinese Medicine 2026cited by 1position: middledoi
Additional file 1 of Clinical efficacy and multi-omics analysis of Si–Ni–San for depression treatment in breast cancer patients: a randomized, double-blind, placebo-controlled, crossover trial
Open MIND 2026cited by 0position: middledoi
Additional file 1 of Clinical efficacy and multi-omics analysis of Si–Ni–San for depression treatment in breast cancer patients: a randomized, double-blind, placebo-controlled, crossover trial
Figshare 2026cited by 0position: middledoi
Liquiritin in Aiduqing formula inhibits breast cancer neoangiogenesis by suppressing CTSK-mediated lysosomal degradation of CXCL1 in tumor-associated macrophages
Phytomedicine 2025cited by 2position: middledoi
Tumor-associated macrophages/C-X-C motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via IGF1R/STAT3/HMGB1 signaling
Cell Death and Disease 2024cited by 34position: middledoi
Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling
Journal of Experimental & Clinical Cancer Research 2024cited by 26position: middledoi
Brain‐Targeted Black Phosphorus‐Based Nanotherapeutic Platform for Enhanced Hypericin Delivery in Depression
Small 2024cited by 13position: middledoi
Developing liver-targeted naringenin nanoparticles for breast cancer endocrine therapy by promoting estrogen metabolism
Journal of Nanobiotechnology 2024cited by 8position: middledoi
Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment
International Journal of Nanomedicine 2023cited by 36position: middledoi
Cefoselis enhances breast cancer chemosensitivity by directly targeting GRP78/LRP5 signalling of cancer stem cells
Clinical and Translational Medicine 2023cited by 5position: middledoi
Dying cell-released exosomal CXCL1 promotes breast cancer metastasis by activating TAM/PD-L1 signaling
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 0position: middledoi
Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway
Journal of Advanced Research 2022cited by 51position: firstdoi
Corrigendum: Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling
Frontiers in Pharmacology 2022cited by 1position: middledoi
Ursolic Acid Inhibits Breast Cancer Metastasis by Suppressing Glycolytic Metabolism via Activating SP1/Caveolin-1 Signaling
Frontiers in Oncology 2021cited by 56position: middledoi
Sini San Inhibits Chronic Psychological Stress-Induced Breast Cancer Stemness by Suppressing Cortisol-Mediated GRP78 Activation
Frontiers in Pharmacology 2021cited by 35position: middledoi
Development and Validation of a Risk Prediction Model for Breast Cancer Prognosis Based on Depression-Related Genes
SSRN Electronic Journal 2021cited by 0position: middledoi
Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway
Phytomedicine 2020cited by 44position: middledoi
Synthesis and three-dimensional quantitative structure-activity relationship study of quinazoline derivatives containing a 1,3,4-oxadiazole moiety as efficient inhibitors against Xanthomonas axonopodis pv. citri
Molecular Diversity 2018cited by 24position: middledoi
Synthesis and biological activity of myricetin derivatives containing 1,3,4-thiadiazole scaffold
Chemistry Central Journal 2017cited by 62position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhiyu Wang · Guangzhou University of Chinese Medicine14 papers (2020–2025)Neng Wang · Suizhou Central Hospital12 papers (2020–2024)Yifeng Zheng · Guangzhou University of Chinese Medicine11 papers (2020–2025)Bo Pan · Guangzhou University of Chinese Medicine11 papers (2021–2024)Shengqi Wang · Guangzhou University of Chinese Medicine10 papers (2020–2024)Xuan Wang · Sun Yat-sen University Cancer Center8 papers (2020–2023)Bowen Yang · Guangzhou University of Chinese Medicine5 papers (2020–2025)Bowen Yang · Guangzhou University of Chinese Medicine4 papers (2021–2024)Honglin Situ · Guangzhou University of Chinese Medicine4 papers (2021–2026)Shengqi Wang · Guangzhou University of Chinese Medicine4 papers (2025–2026)Ying Chen · Guangzhou University of Chinese Medicine3 papers (2026–2026)Yan Li · Guangzhou University of Chinese Medicine3 papers (2026–2026)Lingling Yang · Guangzhou University of Chinese Medicine3 papers (2026–2026)Li Guo · Guangzhou University of Chinese Medicine3 papers (2026–2026)Tongkai Chen · Guangzhou University of Chinese Medicine3 papers (2023–2024)Li Yunxi · Guangzhou University of Chinese Medicine3 papers (2026–2026)Hanxu Tan · Guangzhou University of Chinese Medicine3 papers (2023–2024)Shaowen Zhong · Guangzhou University of Chinese Medicine3 papers (2026–2026)Yifeng Zheng · Guangzhou University of Chinese Medicine3 papers (2026–2026)Miao Yu · Guangzhou University of Chinese Medicine3 papers (2026–2026)